Cibc Private Wealth Group, LLC Ionis Pharmaceuticals Inc Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,125 shares of IONS stock, worth $33,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,125
Previous 2,425
53.61%
Holding current value
$33,941
Previous $97,000
59.79%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
411Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$497 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$427 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$346 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$311 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$237 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...